![Michael Bettess](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Bettess
Président chez
Currus Biologics Pty Ltd.
Profil
Michael Bettess is currently the Chairman at Currus Biologics Pty Ltd., the Director at Cincera Therapeutics Pty Ltd., and the Senior Investment Manager at Brandon Capital Partners Pty Ltd. He previously worked as the Director at Heart Metabolics Ltd. and as the Investment Manager at Trans Tasman Fund Management Pty Ltd. Dr. Bettess obtained an MBA from LaTrobe University in 2008.
Postes actifs de Michael Bettess
| Sociétés | Poste | Début |
|---|---|---|
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Private Equity Investor | 01/02/2016 |
Cincera Therapeutics Pty Ltd.
 Cincera Therapeutics Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Develops molecule drugs | Directeur/Membre du Conseil | - |
Currus Biologics Pty Ltd.
 Currus Biologics Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops cell therapies to treat cancers | Président | - |
Anciens postes connus de Michael Bettess
| Sociétés | Poste | Fin |
|---|---|---|
Trans Tasman Fund Management Pty Ltd.
 Trans Tasman Fund Management Pty Ltd. Investment ManagersFinance TTCF invests in early stage commercialization of intellectual property developed at the University of Auckland and four Australian universities. It focuses on companies operating in the fields of technology, life sciences, information & communication technology and engineering/cleantech and also provides pre-seed, seed & early stage capital with an follow on investments. | Private Equity Investor | - |
Heart Metabolics Ltd.
 Heart Metabolics Ltd. BiotechnologyHealth Technology Develops medical therapy for the treatment of heart failure | Directeur/Membre du Conseil | - |
Formation de Michael Bettess
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
LaTrobe University
 LaTrobe University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Trans Tasman Fund Management Pty Ltd.
Trans Tasman Fund Management Pty Ltd. Investment ManagersFinance TTCF invests in early stage commercialization of intellectual property developed at the University of Auckland and four Australian universities. It focuses on companies operating in the fields of technology, life sciences, information & communication technology and engineering/cleantech and also provides pre-seed, seed & early stage capital with an follow on investments. | Finance |
Heart Metabolics Ltd.
Heart Metabolics Ltd. BiotechnologyHealth Technology Develops medical therapy for the treatment of heart failure | Health Technology |
Cincera Therapeutics Pty Ltd.
Cincera Therapeutics Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Develops molecule drugs | Commercial Services |
Currus Biologics Pty Ltd.
Currus Biologics Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops cell therapies to treat cancers | Health Technology |
